A large pharma company wanted to better understand disease progression for patients with an age-related illness, and worked with CareSet and another claims vendor to track comorbidities, procedures, and other claims-related events both prior to and after diagnosis date. Our work resulted in a change to the overall design study and better quality data for the outcomes research group.
CareSet decodes Medicare claims data to guide new drug launches.
This case study explores how you can bring your market into laser focus with CareSet Target and aim your sales force where your product is most needed.
Knowing the scale of your market and the trends that point to opportunities for your product is what CareSet Pathway is all about. This case study looks at trends in cancer patient readmissions and points to where those trends are most pronounced.
CareSet hosted “Cancer Data: Driving Medication Purchase Decisions” at SXSW Interactive on March 12, 2017 at the Austin Convention Center.
In March 2011, the FDA approved a little molecule called Ipilimumab, better known as Yervoy. Learn why we think Yervoy’s approval marked the dawn of the immuno-oncology age.
For outcomes research teams, understanding disease progression creates new patient segmentation. For brand managers, knowing which practices to talk to enables more targeted outreach in less time.
CareSet in Action
Patch software gives you the power to find and analyze information using your own parameters. We provide fresh, rich data – you view it like never before
Let us show you what CareSet can do!
Let’s get in touch!